Skip to main content

Table 2 Cancer Phenotypes for FHS 100K Project: Results of Association Analyses*

From: A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study

2a. GEE results ranked by p-value

SNP

Chr

Physical Position

GEE p-value

FBAT p-value

Gene region (within 60 kb)

BREAST CANCER

rs2075555

17

45,629,290

8.3 × 10 -8

0.157

COL1A1

rs6556756

5

163,821,858

5.0 × 10 -7

0.114

 

rs1154865

12

72,276,104

6.6 × 10 -7

0.052

 

rs1978503

18

51,815,280

9.66 × 10 -7

0.287

 

rs1926657

13

94,672,957

1.9 × 10 -6

0.072

ABCC4

rs10263639

7

66,503,417

2.7 × 10 -6

0.590

 

rs10490113

2

59,410,998

4.7 × 10 -6

0.077

 

rs458685

21

30,099,382

6.0 × 10 -6

0.064

GRIK1

rs1876206

15

46,687,878

6.0 × 10 -6

0.742

FBN1

rs9314033

5

163,822,784

1.2 × 10 -5

0.058

 

rs10486490

7

25,846,789

1.3 × 10 -5

0.245

 

rs9325024

5

146,185,979

1.7 × 10 -5

0.112

PPP2R2B

rs1294255

1

229,808,093

1.9 × 10 -5

0.470

 

rs10513754

3

178,681,862

2.8 × 10 -5

0.189

 

rs10501093

11

27,946,695

3.0 × 10 -5

0.066

KIF18A

PROSTATE CANCER

rs9311171

3

37,971,481

1.8 × 10 -6

0.392

CTDSPL

rs1529276

13

102,726,008

1.8 × 10 -6

0.071

 

rs10498792

6

51,774,590

3.0 × 10 -6

0.285

PKHD1

rs4466137

5

83,021,495

3.1 × 10 -6

0.305

HAPLN1

rs345013

3

146,656,486

5.1 × 10 -6

0.002

 

rs10505137

8

111,210,785

1.3 × 10 -5

0.002

 

rs1873038

3

175,020,343

1.8 × 10 -5

0.317

NLGN1

rs8019932

14

29,676,177

1.9 × 10 -5

0.019

 

rs344985

3

146,619,475

2.1 × 10 -5

0.002

 

rs1920676

11

15,789,323

2.2 × 10 -5

0.196

 

rs10511206

10

127,209,365

2.4 × 10 -5

0.028

 

rs1037569

5

119,954,204

2.8 × 10 -5

0.165

 

rs2109312

2

128,292,061

3.0 × 10 -5

0.786

WDR33

rs1352416

3

174,963,409

3.4 × 10 -5

0.201

NLGN1

rs1440714

11

15,,790,399

3.7 × 10 -5

0.223

 

2b. FBAT results ranked by p-value

SNP

Chr

Physical Position

GEE p-value

FBAT p-value

Gene Region (within 60 kb)

BREAST CANCER

rs7711990

5

180,307,504

0.010

8.4 × 10 -5

 

rs1451125

4

137,449,995

0.008

9.5 × 10 -5

 

rs4266352

4

109,823,951

0.001

1.2 × 10 -4

 

rs6720918

2

122,873,276

0.027

1.9 × 10 -4

 

rs6101183

20

59,025,355

0.132

2.0 × 10 -4

 

rs9307064

4

90,503,827

0.159

2.2 × 10 -4

 

rs10512287

9

101,538,523

0.807

2.3 × 10 -4

GRIN3A

rs7190881

16

7,368,424

0.475

2.9 × 10 -4

 

rs2224402

1

229,359,076

0.418

3.1 × 10 -4

C1orf57

rs10516690

4

84,822,792

0.954

3.7 × 10 -4

 

rs10487920

7

145,895,727

0.085

3.9 × 10 -4

CNTNAP2

rs6479347

9

91,348,121

0.017

4.5 × 10 -4

 

rs1924587

13

96,195,380

0.020

4.6 × 10 -4

HS6ST3

rs2059273

16

5,991,144

0.005

4.9 × 10 -4

A2BP1

rs2822669

21

14,752,449

0.029

5.7 × 10 -4

SAMSN1

PROSTATE CANCER

rs657057

6

56,402,241

0.109

3.4 × 10 -5

DST

rs6691482

1

170,274,521

0.007

4.0 × 10 -5

SLC9A11

rs4378061

9

10,930,127

0.633

6.6 × 10 -5

 

rs2056387

1

234,250,153

0.159

1.1 × 10 -4

RYR2

rs2274626

1

176,253,589

0.005

1.4 × 10 -4

NPHS2

rs181247

17

53,562,730

0.552

3.2 × 10 -4

OR4D1|OR4D2

rs7827348

8

3,020,222

0.054

3.6 × 10 -4

 

rs255561

5

82,386,566

0.040

3.9 × 10 -4

XRCC4

rs1504858

4

137,063,555

0.010

3.9 × 10 -4

 

rs954709

4

167,317,424

0.049

4.2 × 10 -4

 

rs2179443

20

37,450,516

0.057

4.4 × 10 -4

 

rs35239

5

68,064,834

0.657

4.6 × 10 -4

 

rs477516

8

16,758,362

0.057

5.1 × 10 -4

 

rs595725

1

28,993,331

0.239

5.3 × 10 -4

OPRD1

rs10515322

5

101,539,543

0.051

5.4 × 10 -4

SLCO4C1

  1. *Autosomal SNPs with genotypic call rate ≥80%, minor allele frequency ≥10%, Hardy-Weinberg test p ≥ 0.001, and ≥10 informative families for FBAT. The physical location of the SNPs was based on Build 35 of Genome; however, the 100K web browser was based on Build 36